Monday, September 19, 2016

Dexedrine


Dexedrine is a brand name of dextroamphetamine, approved by the FDA in the following formulation(s):


DEXEDRINE (dextroamphetamine sulfate - capsule, extended release; oral)



  • Manufacturer: COREPHARMA

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [AB], 15MG [RLD][AB], 5MG [AB]

Has a generic version of Dexedrine been approved?


Yes. The following products are equivalent to Dexedrine:


dextroamphetamine sulfate capsule, extended release; oral



  • Manufacturer: BARR

    Approval date: January 18, 2002

    Strength(s): 10MG [AB], 15MG [AB], 5MG [AB]


  • Manufacturer: MALLINCKRODT

    Approval date: May 6, 2003

    Strength(s): 10MG [AB], 15MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dexedrine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Dexedrine.

See also...

  • Dexedrine Consumer Information (Wolters Kluwer)
  • Dexedrine Spansule Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Dexedrine Consumer Information (Cerner Multum)
  • Dexedrine Spansule Consumer Information (Cerner Multum)
  • Dexedrine Advanced Consumer Information (Micromedex)
  • Dexedrine Spansules Advanced Consumer Information (Micromedex)
  • Dextroamphetamine Consumer Information (Wolters Kluwer)
  • Dextroamphetamine Solution Consumer Information (Wolters Kluwer)
  • Dextroamphetamine Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Dextroamphetamine Consumer Information (Cerner Multum)
  • Dextroamphetamine Advanced Consumer Information (Micromedex)
  • Dextroamphetamine AHFS DI Monographs (ASHP)
  • Dextroamphetamine Sulfate AHFS DI Monographs (ASHP)

No comments:

Post a Comment